Mo1757 THE RISK OF BLOOD TRANSFUSION WITH THE USE OF PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DURING HOSPITALIZATION FOR INFLAMMATORY BOWEL DISEASE EXACERBATION: A TIME TO EVENT ANALYSIS

Inflammatory bowel disease (IBD) exacerbation increases the risk of venous thromboembolism (VTE), and current guidelines recommend pharmacologic VTE prophylaxis (PVTEP) during hospitalization. Compliance with these guidelines is poor, in part due to the physician and patient concerns that PVTEP may worsen anemia and/or bleeding. This risk in the IBD population is poorly defined.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Poster abstracts Source Type: research